Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 9012929, 9 pages
https://doi.org/10.1155/2017/9012929
Review Article

Chinese Classical Formula Sijunzi Decoction and Chronic Atrophic Gastritis: Evidence for Treatment Approach?

1Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Haiyuncang Street, Dongcheng District, Beijing 100700, China
2Department of Gastroenterology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Huajiadi Street, Chaoyang District, Beijing 100102, China

Correspondence should be addressed to Yong’an Ye; moc.361.piv@nagnoyey

Received 1 March 2017; Accepted 26 July 2017; Published 24 August 2017

Academic Editor: Gioacchino Calapai

Copyright © 2017 Danan Gan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Vannella, E. Lahner, and B. Annibale, “Risk for gastric neoplasias in patients with chronic atrophic gastritis: A critical reappraisal,” World Journal of Gastroenterology, vol. 18, no. 12, pp. 1279–1285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Feldman and E. L. Lee, “Gastritis,” in Sleisinger and Fordtran’s Gastrointestinal and Liver Disease, M. Feldman, Ed., chapter 52, pp. 870–872, Elsevier Saunders, Philadelphia, Pa, USA, 10th edition, 2016. View at Google Scholar
  3. Y. Zhang, A. Zhou, Y. Liu et al., “Exploratory factor analysis for validating traditional chinese syndrome patterns of chronic atrophic gastritis,” Evidence-Based Complementary & Alternative Medicine, vol. 2016, Article ID 6872890, 2016. View at Google Scholar
  4. M. A. Adamu, M. N. Weck, L. Gao, and H. Brenner, “Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies,” European Journal of Epidemiology, vol. 25, no. 7, pp. 439–448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Giannakis, S. L. Chen, S. M. Karam, L. Engstrand, and J. I. Gordon, “Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 11, pp. 4358–4363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Carrasco and A. H. Corvalan, “Helicobacter pylori-induced chronic gastritis and assessing risks for gastric cancer,” Gastroenterology Research and Practice, vol. 2013, Article ID 393015, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Inoue, K. Tajima, A. Matsuura et al., “Severity of chronic atrophic gastritis and subsequent gastric cancer occurrence: a 10-year prospective cohort study in Japan,” Cancer Letters, vol. 161, no. 1, pp. 105–112, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Y. Fang, W. Z. Liu, Y. Shi, Z. Z. Ge, and S. D. Xiao, “Consensus on chronic gastritis in China - second national consensus meeting on chronic gastritis (14–16 september 2006 Shanghai, China),” Journal of Digestive Diseases, vol. 8, no. 2, pp. 107–119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C.-K. Ching and S.-K. Lam, “Antacids: indications and limitations,” Drugs, vol. 47, no. 2, pp. 305–317, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. F. L. Hu, P. J. Hu, and W. Z. Liu, “Third chinese national consensus report on the management of helicobacter pylori infection,” Journal of Digestive Diseases, vol. 9, no. 3, pp. 178–184, 2008. View at Publisher · View at Google Scholar
  11. G. I. Leontiadis and A. C. Ford, “Helicobacter pylori eradication: gastric cancer prevention,” BMJ Clinical Evidence, vol. 2015, p. 0406, 2015. View at Google Scholar
  12. P. Porcelli and M. De Carne, “Non-fearful panic disorder in gastroenterology,” Psychosomatics, vol. 49, no. 6, pp. 543–545, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Du, Y. Bai, P. Xie et al., “Chronic gastritis in China: a national multi-center survey,” BMC Gastroenterology, vol. 14, no. 1, 2014. View at Publisher · View at Google Scholar
  14. N. Zendehdel, S. Nasseri-Moghaddam, R. Malekzadeh, S. Massarrat, M. Sotoudeh, and F. Siavoshi, “Helicobacter pylori reinfection rate 3 years after successful eradication,” Journal of Gastroenterology and Hepatology, vol. 20, no. 3, pp. 401–404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Wei, L. X. Ma, S. J. Yin, J. An, Q. Wei, and J. X. Yang, “Huangqi Jianzhong Tang for treatment of chronic gastritis: a systematic review of randomized clinical trials,” Evidence-Based Complementary & Alternative Medicine, vol. 2015, Article ID 878164, 2015. View at Google Scholar
  16. H. Song, J. Zhu, and D. Lu, “Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions,” The Cochrane database of systematic reviews, vol. 12, p. CD010623, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Y.-C. Wang, “Medicinal plant activity on Helicobacter pylori related diseases,” World Journal of Gastroenterology, vol. 20, no. 30, pp. 10368–10382, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Safavi, R. Sabourian, and A. Foroumadi, “Treatment of helicobacter pylori infection: current and future insights,” World Journal of Clinical Cases, vol. 4, no. 1, pp. 5–19, 2016. View at Google Scholar
  19. I.-S. Shin, W.-Y. Jeon, H.-K. Shin, S.-W. Cha, and M.-Y. Lee, “Banhabaekchulchunma-tang, a traditional herbal formula attenuates absolute ethanol-induced gastric injury by enhancing the antioxidant status,” BMC Complementary and Alternative Medicine, vol. 13, article 170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. M. Williamson, A. Lorenc, A. Booker, and N. Robinson, “The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China,” Journal of Ethnopharmacology, vol. 149, no. 2, pp. 453–462, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Kang, J. R. Guo, Z. Zhang, and X. L. Wang, “Simultaneous quantification of ten active components in traditional chinese formula sijunzi decoction using a UPLC-PDA method,” Journal of Analytical Methods in Chemistry, vol. 2014, Article ID 570359, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Yu, B. Lu, H. Zhang, Y. Zhang, and J. Yan, “Effects of the Sijunzi decoction on the immunological function in rats with dextran sulfate-induced ulcerative colitis,” Biomedical Reports, vol. 5, no. 1, pp. 83–86, 2016. View at Publisher · View at Google Scholar
  23. D. Zhang, W. Shi, Y. Zhao, and X. Zhong, “Adjuvant effects of Sijunzi decoction in chickens orally vaccinated with attenuated newcastle-disease vaccine,” African journal of traditional, complementary, and alternative medicines: AJTCAM / African Networks on Ethnomedicines, vol. 9, no. 1, pp. 120–130, 2012. View at Google Scholar · View at Scopus
  24. B. Xiong and H. Qian, “Effects of Sijunzi decoction and Yupingfeng powder on expression of janus kinase-signal transducer and activator of transcription signal pathway in the brain of spleen-deficiency model rats,” Journal of Traditional Chinese Medicine, vol. 33, no. 1, pp. 78–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Lu, J.-T. Wang, and R.-X. Chen, “Observation on therapeutic effect of acupuncture combined with drug for treatment of intestinal metaplasia of chronic atrophic gastritis,” Zhongguo Zhen Jiu = Chinese acupuncture & moxibustion, vol. 25, no. 7, pp. 457–459, 2005. View at Google Scholar · View at Scopus
  26. W. R. Zhong, Y. X. Huang, and J. P. Cui, “Clinical study on modified sijunzi decoction in treating intestinal metaplasia of gastric mucosa,” Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine/Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban, vol. 17, no. 8, pp. 462–464, 1997. View at Google Scholar · View at Scopus
  27. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” Annals of Internal Medicine, vol. 151, no. 4, Article ID e1000097, pp. 264–269, 2009. View at Publisher · View at Google Scholar
  28. M. F. Dixon, R. M. Genta, J. H. Yardley, and P. Correa, “Classification and grading of gastritis. The updated Sydney system,” in Proceedings of the International Workshop on the Histopathology of Gastritis, vol. 20, pp. 1161–1181, American Journal of Surgical Pathology, Houston, Texas, TX, USA, 1994.
  29. J. P. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Version 5. 1. 0, the Cochrane Collaboration, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. F. L. Song, Y. F. Lin, H. R. Li et al., “Effect of modified Sijunzi decoction based triple therapy on atrophic gastritis and expression of PCNA,” Zhong Hua Zhong Yi Yao Za Zhi, vol. 24, no. 3, pp. 367–369, 2009. View at Google Scholar
  31. Z. C. Hu, “Forty-eight cases clinical study of modified Sijunzi decoction treatment for chronic atrophic gastritis,” Zhong Wai Jian Kang Wen Zhai, vol. 8, no. 27, p. 407, 2011. View at Google Scholar
  32. G. J. Sun, Y. P. Zhang, and S. Wu, “Thirty-six cases clinical study of modified Sijunzi decoction treatment for chronic atrophic gastritis with the syndrome of weakened spleen and stomach,” Zhongguo Bao Jian Ying Yang, vol. 12, article 2504, 2012. View at Google Scholar
  33. H. R. Li, “The clinical observation of modified Sijunzi decoction in the management of chronic atrophic gastritis,” Zhongguo Xian Dai Yao Wu Ying Yong, vol. 7, no. 21, pp. 123-124, 2013. View at Google Scholar
  34. Z. M. Zhang, W. J. Yang, B. Ji, and Z. B. Xu, “Modified Sijunzi decoction combined with helicobacter pylori eradication therapy and folate treatment for chronic atrophic gastritis with the syndrome of weakened spleen and stomach: a clinical trial,” Zhe Jiang Zhong Yi Za Zhi, vol. 51, no. 6, pp. 393-394, 2016. View at Google Scholar
  35. G. F. Shen, “Clinical efficacy evaluation of Chinese formula modified Sijunzi decoction treating for chronic atrophic gastritis,” Clinical efficacy evaluation of Chinese formula modified Sijunzi decoction treating for chronic atrophic gastritis, vol. 28, no. 5, pp. 110-111, 2016. View at Google Scholar
  36. Z. L. Guo, Z. N. Su, Z. F. Wang, and X. M. Luo, “Meta-analysis of modified Sijunzi decoction for treating chronic atrophic gastritis,” Zhongguo Shi Yan Fang Ji Xue Za Zhi, vol. 21, no. 24, pp. 204–208, 2015. View at Google Scholar
  37. W. Zhang, S. Wang, and R. Zhang, “Erratum: evidence of Chinese herbal medicine Duhuo Jisheng decoction for knee osteoarthritis: A systematic review of randomised clinical trials (BMJ Open (2016) 6 (e008973)),” BMJ Open, vol. 6, no. 1, Article ID e008973, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Pengfei, L. Xing, X. Yanming, and W. Zhiguo, “The importance and necessity of establishing technical specifications for the registration of traditional chinese medicine clinical studies,” Journal of Alternative and Complementary Medicine, vol. 20, no. 1, pp. 65-66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Moher, S. Hopewell, K. F. Schulz et al., “Erratum: CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials,” Journal of Clinical Epidemiology, vol. 63, no. 8, pp. e1–e37, 2010. View at Publisher · View at Google Scholar · View at Scopus